Multidisciplinary Approach and Therapeutic Advances in the Management of Meningioma: A Comprehensive Review
Main Article Content
Abstract
Meningioma, a predominantly benign intracranial neoplasm originating in the meninges, has been the subject of extensive study in the medical community due to its prevalence, clinical diversity, and associated therapeutic challenges. This article aims to provide a comprehensive review of current advances in the understanding, diagnosis and treatment of meningiomas, focusing on the application of multidisciplinary approaches and innovative therapies.
Through a detailed exploration of the molecular pathogenesis, updated histopathologic classifications, and varied clinical presentations of meningiomas, an in-depth understanding of the inherent heterogeneity of these neoplasms is sought. The importance of advanced neuroimaging, including diffusion-weighted MRI and positron emission tomography, in the accurate assessment of tumor extent and precise surgical planning will be highlighted.
In the therapeutic arena, conventional options, such as surgery and radiation therapy, will be examined in detail and the challenges and limitations associated with these modalities will be discussed. In addition, emerging pharmacologic therapies, such as angiogenesis inhibitors and therapies specifically targeting genetic mutations frequently found in meningiomas, will be reviewed, highlighting their potential to modify the clinical course of the disease.
The multidisciplinary approach, involving close collaboration between neurosurgeons, neuroradiologists, pathologists and oncologists, will be explored in detail, highlighting its crucial role in informed clinical decision making and optimizing patient outcomes. Finally, future prospects and areas of ongoing research, such as immunotherapy and gene therapy, which promise to further revolutionize the therapeutic paradigm for meningiomas, will be outlined.
This article will provide a comprehensive overview of meningiomas, from their molecular basis to state-of-the-art treatment strategies, with the purpose of enriching medical knowledge and fostering a holistic approach in the care of patients affected by this complex pathological entity.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Santamaría A, Martínez R, Astigarra I, Etxebarría J, Sánchez M. Ophthalmologic manifestations in pediatric brain tumors: 58 cases. Arch Soc Esp Oftalmol. 2008; 83:471-8.
II. De Luca S, Aguado AS, De Michelis V, Tisser L, Iribarren G, Eyheremendy E. Orbitocranial pathology of ophthalmologic presentation. Rev. argent. radiol. [Internet]. 2012 Jun;76(2):113-121.
III. Riordan-Eva P, Cunningham E. Vaughan and Asbury: general ophthalmology. 18th ed. Mc.Graw-Hill; 2012. p.p. 533.
IV. Sánchez Méndez F. The optic nerve and vision disorders. Med Integr. 2001;38:390-7.
V. Muñoz Negrete FJ, Rebolleda G. Automated perimetry and neuro-ophthalmology. Correlación topográfica / Automated perimetry and neuro-ophthalmology. Topographic correlation. Arch Soc Esp Oftalmol. 2002;77(8):413-28.
VI. Alegría-Loyola MA. Tumors of the central nervous system. Rev Med Inst Mex Seguro Soc. 2017;55(3):330-40.
VII. Leyva I, Guerrero G, Hernández J. Meningiomas: appearance by tomography and magnetic resonance imaging. Most frequent locations. Annals of Radiology Mexico. 2013;1:36-44.
VIII. Gelabert M, Serramito R. Intracranial meningiomas: II. Diagnosis and treatment. Rev Neurol. 2011;53:226-32.
IX. López Flores G, Samblas García J, Futiérrez-Díaz JA, Bustos P de Salcedo JC, Sallabanda Díaz K. Natural history and classifications of cranial base meningiomas. Rev Mex Neurosci. 2011;12(1):38-49.
X. Casas I. Meningiomas in neuro-oncology. 2016. Neurol Arg. 2016;8(3):210-26.
XI. Cammarata-Scalisi F, Stock F, Zambrano E, Milano M, Arenas de Sotolongo A, Petrosino P. Meningiomas in pediatric age. Presentation of two cases. Pediatr. (Asuncion). 2010;37(3):199-203.
XII. Goldbrunner R, Minniti G, Preusser M, Jenkinson MD, Sallabanda K, Houdart E, von Deimling A, Starvinou P, Lefranc F, Lund-Johansen M, Moyal EC, Brandsma D, Henriksson R, Soffietti R, Weller M. EANO guidelines for the diagnosis and treatment of meningiomas. Lancet Oncol. 2016 Sep;17(9):e383-91.
XIII. Rogers L, Barani I, Chamberlain M, Kaley TJ, McDermott M, Raizer J, et al. Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review. J Neurosurg. 2015 Jan;122(1):4-23.
XIV. Mawrin C, Chung C, Preusser M. Biology and Clinical Management Challenges in Meningioma. American Society of Clinical Oncology. ASCO educational book. asco. org/edbookMD. 2015:e106-e115.
XV. Rockhill J, Mrugala M, Chamberlain MC. Intracranial meningiomas: an overview of diagnosis and treatment. Neurosurg Focus. 23;2007(4);E1:1-7.